Peng Katie 4
4 · Adicet Bio, Inc. · Filed Aug 23, 2024
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Peng Katie
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-21+70,200→ 70,200 totalExercise: $3.38Exp: 2033-07-09→ Common Stock (70,200 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-08-21−70,200→ 0 totalExercise: $2.14Exp: 2033-07-09→ Common Stock (70,200 underlying)
Footnotes (2)
- [F1]Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
- [F2]The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on July 10, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date.